The Urokinase Receptor as a Potential Target in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|19|2359-2376

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.19, 2004-07, pp. : 2359-2376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Steroid receptor coactivator-3 as a potential molecular target for cancer therapy

By Tien Jean Ching-Yi   Xu Jianming  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1085-1096

Informa Healthcare

Access to resources Recommend Favorite

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 32-71

Bentham Science Publishers

Access to resources Recommend Favorite

The NK-1 Receptor: A New Target in Cancer Therapy

By  

Current Drug Targets, Vol. 12, Iss. 6, 2011-06 ,pp. : 909-921

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

The mu opioid receptor: A new target for cancer therapy?

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2681-2688

Blackwell Publishing

Access to resources Recommend Favorite